guidelines for the management of urological cancer - Merseyside ...

References
1. Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, Freedman
LS, Grigor KM, Hall RR, Hargreave TB, Munson K, Newling DW, Richards B, Robinson
MR, Rose MB, Smith PH, Williams JL, Whelan P.
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial
bladder cancer: a further report with 7 years of follow up. J Urol. 1996 Apr;155(4):1233-8.
2. Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK,
Bijnens L. A combined analysis of European Organization for Research and Treatment of
Cancer, and Medical Research Council randomized clinical trials for the prophylactic
treatment of stage TaT1 bladder cancer. European Organization for Research and
Treatment of Cancer Genitourinary Tract Cancer Co-operative Group and the Medical
Research Council Working Party on Superficial Bladder Cancer. J Urol. 1996 Dec; 156(6):
1934-40.
3. Hall RR, Parmar MK, Richards AB, Smith PH. Proposal for changes in cystoscopic
follow up of patients with bladder cancer and adjuvant intravesical chemotherapy. BMJ.
1994 Jan 22;308(6923):257-60.
4. Herr HW. The value of a second transurethral resection in evaluating patients with
bladder tumors. J Urol. 1999 Jul;162(1):74-6.
5. Herr HW Tumor progression and survival of patients with high grade, noninvasive
papillary (TaG3) bladder tumors: 15-year outcome. J Urol. 2000 Jan;163(1):60-1.
6. Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin
reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis
of the published results of randomized clinical trials. J Urol. 2002 Nov;168(5):1964-70.
7. Dalbagni G, Rechtschaffen T, Herr HW. Is transurethral biopsy of the bladder necessary
after 3 months to evaluate response to bacillus Calmette-Guerin therapy?
J Urol. 1999 Sep;162(3 Pt 1):708-9.
8. Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA,
Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED. Maintenance
bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ
transitional cell carcinoma of the bladder: a randomized Southwest
Oncology Group Study. J Urol. 2000 Apr;163(4):1124-9.
9. Griffiths TR, Charlton M, Neal DE, Powell PH.
Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without
maintenance. J Urol. 2002 Jun;167(6):2408-12.
10. Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high
risk superficial bladder tumors? J Urol. 2001 Oct;166(4):1296-9.
11. Kim B, Semelka RC, Ascher SM, et al. Bladder tumor staging: comparison of contrastenhanced
CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging,
and late gadolinium-enhanced imaging. Radiology 1994;193:239-45.
12. Stein J, Lieskovsky G, Cote R. Radical cystectomy in the treatment of invasive bladder
cancer; long term results in 1,054 patients. J Clin Oncol 2001;19:666-75.
Page 25 of 44